The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …

Long COVID refers to the lingering symptoms which persist or appear after the acute illness.
The dominant long COVID symptoms in the two years since the pandemic began (2020 …

Background: As of 8 April 2021, a total of 2.9 million people have died with or from the
coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021 …

Neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection represent a major issue in long coronavirus disease. How SARS-CoV-2 …

Background and Objectives: Symptoms and hemodynamic findings during orthostatic stress
have been reported in both long-haul COVID-19 and myalgic encephalomyelitis/chronic …

The SARS-CoV-2 infection causes COVID-19, which has affected approximately six hundred
million people globally as of 8 2022. Organs and cells harboring angiotensin-converting …

Background: Various symptoms have been associated with COVID-19, but little is known
about the impacts of COVID-19 on the sensory system, risk factors, and the duration of …

Non-steroidal anti-inflammatory drugs (NSAIDs) showed promising clinical efficacy toward
COVID-19 (Coronavirus disease 2019) patients as potent painkillers and anti-inflammatory …

As the world continues to experience the effects of SARS‐CoV‐2, there is evidence to
suggest that the sequelae of viral infection (the post‐COVID‐19 condition; PCC) at both an …

Experimental and theoretical investigation of the anti-hypertensive activity of novel 2-[N-(4-
methylbenzenesulfonyl)-1-phenylformamido]-N-(4-nitrophenyl)-3-phenylpropenamide …